MESAVANT Trademark

Trademark Overview


On Tuesday, July 11, 2023, a trademark application was filed for MESAVANT with the United States Patent and Trademark Office. The USPTO has given the MESAVANT trademark a serial number of 98080024. The federal status of this trademark filing is NOTICE OF ALLOWANCE - CANCELLED as of Monday, October 28, 2024. This trademark is owned by Nogra Pharma Limited. The MESAVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases
mesavant

General Information


Serial Number98080024
Word MarkMESAVANT
Filing DateTuesday, July 11, 2023
Status690 - NOTICE OF ALLOWANCE - CANCELLED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements


Description of MarkThe mark consists of of the stylized wording "MESAVANT". The second letter "A" in the wording includes a circle in the center. A multi-circle loop design appears above the letters "AVAN".
Goods and ServicesPharmaceutical preparation, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNogra Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressDublin 2
IE

Party NameNogra Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressDublin 2
IE

Trademark Events


Event DateEvent Description
Friday, July 14, 2023NEW APPLICATION ENTERED
Saturday, August 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 15, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, December 30, 2023ASSIGNED TO EXAMINER
Saturday, December 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 23, 2024ASSIGNED TO PETITION STAFF
Thursday, October 24, 2024SOU EXTENSION 1 GRANTED
Thursday, October 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024NOTICE OF ALLOWANCE CANCELLED
Monday, October 28, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, October 28, 2024CASE RETURNED TO EXAMINATION
Wednesday, October 2, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, October 2, 2024SOU EXTENSION 1 FILED
Wednesday, October 2, 2024SOU TEAS EXTENSION RECEIVED